Prostate cancers in men with low PSA levels-must we find them?
Article Abstract:
The features and advantages of the prostate-specific antigen (PSA) to identify prostate cancer at an earlier stage are discussed. High-grade cancers produce less PSA than low-grade cancers, so some other methodologies are needed to identify the presence of the disease.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Oxaliplatin, Fluorourcil, and Leucovorin as adjuvant treatment for Colon cancer
Article Abstract:
Colorectal cancer is the second leading cause of death from cancer in western countries. The standard adjuvant treatment of colon cancer is flurouracil plus leucovorin (FL). However no conclusions can be drawn about differences in survival.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Case 20-2004: a 46-year-old woman with Pelvic-Floor relaxation after a second vaginal delivery
Article Abstract:
The experience of a 46-year-old woman who was admitted to the hospital due to pelvic discomforts and urinary symptoms is described. Prevention of Pelvic-Floor dysfunction is discussed.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: New protection needed for new PELs. OSHA releases first ergonomics guidelines. Scaffolding studies back need for better safety training
- Abstracts: Ensuring more holistic care for patients with dyspnoea. The Experience of being a suspended nurse. Risk awareness is a vital factor in fall prevention
- Abstracts: Serum proteomics in cancer diagnosis and management. Nanotechnology and cancer. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors
- Abstracts: Clues to gene activity in inflammation found. Progress in antisense technology